ATC
PACB icon

Adirondack Trust Company’s Pacific Biosciences PACB Stock Holding History

Adirondack Trust Company’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-130
Closed -$3K – 440
2021
Q3 		$3K Hold
130
– – ﹤0.01% 377
2021
Q2 		$5K Hold
130
– – ﹤0.01% 340
2021
Q1 		$4K Hold
130
– – ﹤0.01% 352
2020
Q4 		$4K Buy
+130
New +$2.21K ﹤0.01% 329

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Adirondack Trust Company's PACB Position: Q4 2021 in Review

Adirondack Trust Company sold out of Pacific Biosciences (PACB) in Q4 2021, closing a stake of 130 shares — an estimated $3K sold.

Adirondack Trust Company first reported a position in PACB in Q4 2020 and held it in 4 quarters. The position peaked at $5K in Q2 2021. 256 funds tracked by Wall St. Rank hold PACB as of Q4 2021.

  • Adirondack Trust Company reported no remaining Pacific Biosciences position as of Q4 2021 after selling out during the quarter.
  • Adirondack Trust Company sold 130 Pacific Biosciences shares in Q4 2021, an estimated $3K.
  • Adirondack Trust Company first reported a position in Pacific Biosciences in Q4 2020 and held it in 4 quarters.
  • Adirondack Trust Company's Pacific Biosciences position peaked at $5K in Q2 2021.
  • 256 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2021.

Based on Adirondack Trust Company's 13F filing for Q4 2021, filed 13 Jan 2022.